USANA Net Income from 2010 to 2026
| USNA Stock | USD 21.68 0.31 1.45% |
Net Income | First Reported 1995-03-31 | Previous Quarter 9.7 M | Current Value -6.5 M | Quarterly Volatility 10.1 M |
Check USANA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USANA Health's main balance sheet or income statement drivers, such as Interest Expense of 177 K, Total Revenue of 597.3 M or Gross Profit of 482.2 M, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or PTB Ratio of 2.27. USANA financial statements analysis is a perfect complement when working with USANA Health Valuation or Volatility modules.
USANA | Net Income | Build AI portfolio with USANA Stock |
Analyzing USANA Health's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing USANA Health's current valuation and future prospects.
Latest USANA Health's Net Income Growth Pattern
Below is the plot of the Net Income of USANA Health Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in USANA Health Sciences financial statement analysis. It represents the amount of money remaining after all of USANA Health Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is USANA Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in USANA Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 42.06 M | 10 Years Trend |
|
Net Income |
| Timeline |
USANA Net Income Regression Statistics
| Arithmetic Mean | 75,007,948 | |
| Geometric Mean | 54,403,646 | |
| Coefficient Of Variation | 43.86 | |
| Mean Deviation | 25,673,931 | |
| Median | 69,350,000 | |
| Standard Deviation | 32,901,446 | |
| Sample Variance | 1082.5T | |
| Range | 125.9M | |
| R-Value | 0.12 | |
| Mean Square Error | 1139.1T | |
| R-Squared | 0.01 | |
| Significance | 0.66 | |
| Slope | 755,482 | |
| Total Sum of Squares | 17320.1T |
USANA Net Income History
Other Fundumenentals of USANA Health Sciences
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
USANA Health Net Income component correlations
About USANA Health Financial Statements
USANA Health stakeholders use historical fundamental indicators, such as USANA Health's Net Income, to determine how well the company is positioned to perform in the future. Although USANA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in USANA Health's assets and liabilities are reflected in the revenues and expenses on USANA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USANA Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income | 48.4 M | 55.1 M | |
| Net Income Applicable To Common Shares | 79.8 M | 65.4 M | |
| Net Income From Continuing Ops | 48.4 M | 91.9 M | |
| Net Income Per Share | 2.98 | 1.56 | |
| Net Income Per E B T | 0.56 | 0.51 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Check out the analysis of USANA Health Correlation against competitors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive USANA Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.04) | Earnings Share 0.9 | Revenue Per Share | Quarterly Revenue Growth 0.067 | Return On Assets |
Understanding USANA Health Sciences requires distinguishing between market price and book value, where the latter reflects USANA's accounting equity. The concept of intrinsic value—what USANA Health's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push USANA Health's price substantially above or below its fundamental value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, USANA Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.